EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Immunohistochemical analysis of thyroid transcription factor-1 in type A and AB thymomas comparing multiple primary antibody clones

Ayaka Mitsui, Jumpei Kashima, Satsuki Kishikawa, Shun-Ichi Watanabe, Yasushi Goto, Yasushi Yatabe

Cancer Treatment and Research Communications · 2025

DOI: 10.1016/j.ctarc.2025.101045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Treatment and Research Communications, 2025. Verfasst von Ayaka Mitsui und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Pathology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, Tokyo 104-0045, Japan. Hauptthemen laut MEDLINE: Thymoma, Thyroid Nuclear Factor 1, Thymus Neoplasms, Transcription Factors. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thyroid transcription factor-1 (TTF-1) is expressed in the thyroid gland, lungs, and brain, and has also been reported in thymomas. While some studies have suggested TTF-1 as a specific marker for type AB thymoma, others have noted significant variability, often due to small case numbers. In this study, TTF-1 expression was evaluated in 50 cases of type A and AB thymomas using three distinct clones (8G7G3/1, SPT24, and SP141), and quantified with a four-grade scale. Additionally, CD20 expression and GTF2I mutation status were analyzed. TTF-1 expression analyses with the SPT24 and SP141 clones yielded a score of 3 (defined as positivity in >50 % of cells) in 20 % and 18 % of thymomas, respectively. In contrast, the 8G7G3/1 clone showed a score of 0 (positivity in

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThymomaThyroid Nuclear Factor 1Thymus NeoplasmsTranscription FactorsHumansMaleFemaleMiddle AgedAgedImmunohistochemistryAdultBiomarkers, TumorMutationAged, 80 and overTranscription Factors, TFII

Stichwörter der Autor:innen

GTF2IImmunohistochemistryThymomaThyroid transcription factor-1

Substanzen

Thyroid Nuclear Factor 1NKX2-1 protein, humanBiomarkers, TumorTranscription FactorsGTF2I protein, humanTranscription Factors, TFII

Autor:innen und Institutionen

  • Department of Diagnostic Pathology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, Tokyo 104-0045, Japan.
  • Department of Thoracic Surgery, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, Tokyo 104-0045, Japan.
  • Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, Tokyo 104-0045, Japan.
  • Department of Diagnostic Pathology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, Tokyo 104-0045, Japan. Electronic address: yyatabe@ncc.go.jp.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Mitsui, A., Kashima, J., Kishikawa, S., Watanabe, S. I., Goto, Y., & Yatabe, Y. (2025). Immunohistochemical analysis of thyroid transcription factor-1 in type A and AB thymomas comparing multiple primary antibody clones. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2025.101045

Vancouver

Mitsui A, Kashima J, Kishikawa S, Watanabe SI, Goto Y, Yatabe Y. Immunohistochemical analysis of thyroid transcription factor-1 in type A and AB thymomas comparing multiple primary antibody clones. Cancer Treatment and Research Communications. 2025. doi:10.1016/j.ctarc.2025.101045

BibTeX
@article{Mitsui2025,
  author = {Mitsui, Ayaka and Kashima, Jumpei and Kishikawa, Satsuki and Watanabe, Shun-Ichi and Goto, Yasushi and Yatabe, Yasushi},
  title = {Immunohistochemical analysis of thyroid transcription factor-1 in type A and AB thymomas comparing multiple primary antibody clones},
  journal = {Cancer Treatment and Research Communications},
  year = {2025},
  doi = {10.1016/j.ctarc.2025.101045}
}
Kostenlos starten →